Results 101 to 110 of about 42,452 (228)
Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis [PDF]
, 2019 Background: Etelcalcetide is an intravenous calcimimetic approved for treatment of secondary hyperparathyroidism (sHPT) in patients receiving hemodialysis. Besides lowering parathyroid hormone (PTH), etelcalcetide also significantly reduces fibroblast
Block, Geoffrey A. +9 more
core +1 more source
Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss
Journal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.ABSTRACT Osteoporosis is a prevalent skeletal disorder characterised by progressive reduction in bone mass, microarchitectural deterioration, and increased fracture susceptibility. In India, approximately one‐third of the elderly population is affected by bone‐related disorders, and the global burden of osteoporosis continues to rise.
Pramoda G. +5 more
wiley +1 more source
Hyperparathyroidism and hyperfunctioning supernumary glands : considerations for challenging management [abstract] [PDF]
, 2010 Hyperparathyroidism can be treated surgically with high success rates. While the majority of patients have four glands, the presence of a supernumerary gland may be encountered as a normal anatomic variant in up to 13% of the population.
Page, Matthew, Showmaker, Jason
core
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease [PDF]
, 2016 Secondary hyperparathyroidism (SHPT) is a common complication of CKD and is part of the chronic kidney disease-mineral bone disorder (CKD-MBD). SHPT is associated with increased risk of fracture and mortality, thus SHPT control is recommended as kidney ...
Khwaja, A., Salam, S.N., Wilkie, M.E.
core +1 more source
A Swelling in the Mouth in a Chronic Hemodialysis Patient
Case Reports in Nephrology, 2016 Oral manifestations of severe secondary hyperparathyroidism include maxillary and mandibular deformities, brown tumors, dental abnormalities, and metastatic calcification of soft tissues.
Arnaud Devresse +3 more
doaj +1 more source
Bradycardia secondary to primary hyperparathyroidism
Journal of International Medical Research, 2019 Clinical doctors rarely associate hyperparathyroidism with significant bradyarrhythmia. We report a rare case of a patient initially misdiagnosed with primary sick sinus syndrome, which was eventually shown to be secondary to primary hyperparathyroidism.
Fei Liu +3 more
doaj +1 more source
BMC Endocrine Disorders, 2019 Background Renal hyperparathyroidism is a common complication of chronic kidney disease (CKD) or end-stage renal disease (ESRD) characterized by elevated parathyroid hormone levels secondary to derangements in the homeostasis of calcium, phosphate, and ...
Tsai-Sung Tai +3 more
doaj +1 more source
Calcific uraemic arteriolopathy - A mini-review [PDF]
, 2016 Calcific Uraemic Arteriolopathy (CUA) or calciphylaxis, is a thrombotic disorder of skin and subcutaneous tissue which typically presents with painful purpuric nodules that may progress to necrotic ulcers, and is a severe, life-threatening condition. CUA
Agapii, Rodica +7 more
core
Impaired Insulin sensitivity and Insulin secretion in Haemodialysis patients with and without Secondary Hyperparathyroidism [PDF]
, 2004 The aim of our study was to investigate insulin sensitivity and beta cell function in hemodialysis (HD) patients without diabetes. We hypothesized that parathyroid gland function was a determinant of insulin sensitivity and/or beta cell function.
Gluvic, Zoran M. +5 more
core
Tumoral Calcinosis in Secondary Hyperparathyroidism
Philippine Journal of Otolaryngology Head and Neck Surgery, 2016 Objective: To report a case of tumoral calcinosis from secondary hyperparathyroidism and to describe its surgical management. Methods: Study Design: Case report Setting: Tertiary public university hospital Patient: One ...
Reinzi Luz S. Bautista +4 more
doaj +1 more source